Must be by market close (end of 2026)

For background:

https://www.nytimes.com/2024/11/19/magazine/ozempic-junk-food.html

Or this tweet:

https://x.com/ChristosArgyrop/status/1889163083123175583

Resolves YES if there is evidence that a junk food or fast food company (I will apply this label very generously and broadly in edge cases) has used some sort of engineered additive specifically to mitigate the effects of GLP-1 agonists like Ozempic.

I will resolve to credible sources, but may need to use my own discretion in edge cases (thus I will not bet in this market to remain objective).

The additive must actually be at least somewhat effective. Just because the company says it will help, doesn't mean it actually will, but I will again be fairly generous in what an effective additive might mean, if there are edge cases (for example, if the literature is mixed on whether an additive might be effective for this purpose, I would probably still resolve YES, even if there's uncertainty). Title specifies an "engineered additive", so I wouldn't resolve this YES if it's a very common ingredient, or for example, a broad class of ingredients (like, research shows GLP-1 agonists are X% less effective on high fiber foods, so fast food companies increase fiber content). I'm looking for a specific additive that works to counteract the effects of GLP-1 agonists to make the consumer (presumably) eat more. Again, I will be fairly broad in this definition, however.